10-69180307-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000359655.9(SUPV3L1):c.16G>T(p.Ala6Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 1,613,668 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000359655.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SUPV3L1 | NM_003171.5 | c.16G>T | p.Ala6Ser | missense_variant | 1/15 | ENST00000359655.9 | NP_003162.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SUPV3L1 | ENST00000359655.9 | c.16G>T | p.Ala6Ser | missense_variant | 1/15 | 1 | NM_003171.5 | ENSP00000352678 | P1 | |
SUPV3L1 | ENST00000471069.5 | n.58G>T | non_coding_transcript_exon_variant | 1/6 | 1 | |||||
SUPV3L1 | ENST00000422378.1 | c.16G>T | p.Ala6Ser | missense_variant | 1/6 | 5 | ENSP00000409072 | |||
SUPV3L1 | ENST00000483572.5 | n.27G>T | non_coding_transcript_exon_variant | 1/8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000803 AC: 2AN: 249010Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135098
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461438Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727038
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2024 | The c.16G>T (p.A6S) alteration is located in exon 1 (coding exon 1) of the SUPV3L1 gene. This alteration results from a G to T substitution at nucleotide position 16, causing the alanine (A) at amino acid position 6 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at